Stockreport

Onconova Therapeutics Announces Positive Preclinical Data for Third-Generation Oral CDK4/6 + ARK5 Inhibitor and dual FLT3 and Src inhibitor at 2017 American Association of Cancer Research...

Onconova Therapeutics, Inc.  (ONTX) 
Last onconova therapeutics, inc. earnings: 11/12 05:10 pm Check Earnings Report
US:NASDAQ Investor Relations: investor.onconova.com/investor-overview
PDF Comparative biological studies with PalbociclibSingle-agent activity of ON 123300 in various models including multiple myeloma and lymphoma NEWTOWN, Pa., April 04, 201 [Read more]